Business Description
![Aethlon Medical Inc Aethlon Medical Inc logo](https://static.gurufocus.com/logos/0C00000CYJ.png?14)
Aethlon Medical Inc
NAICS : 339112
SIC : 5999
ISIN : US00808Y2081
Description
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.78 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -0.08 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 9.1 | |||||
3-Year EPS without NRI Growth Rate | 9.2 | |||||
3-Year FCF Growth Rate | 9.9 | |||||
3-Year Book Growth Rate | -34.4 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.3 | |||||
9-Day RSI | 37.86 | |||||
14-Day RSI | 37.5 | |||||
6-1 Month Momentum % | -65 | |||||
12-1 Month Momentum % | -84.1 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.4 | |||||
Quick Ratio | 3.4 | |||||
Cash Ratio | 2.97 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -29.4 | |||||
Shareholder Yield % | -21.14 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -117.67 | |||||
ROA % | -94.16 | |||||
ROIC % | -491.29 | |||||
ROC (Joel Greenblatt) % | -582.41 | |||||
ROCE % | -113.12 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.21 | |||||
Price-to-Tangible-Book | 0.21 | |||||
EV-to-EBIT | -0.11 | |||||
EV-to-EBITDA | -0.11 | |||||
EV-to-FCF | -0.13 | |||||
Price-to-Net-Current-Asset-Value | 0.32 | |||||
Price-to-Net-Cash | 0.4 | |||||
Earnings Yield (Greenblatt) % | -909.09 | |||||
FCF Yield % | -164.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AEMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aethlon Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -4.9 | ||
Beta | 2.08 | ||
Volatility % | 90.94 | ||
14-Day RSI | 37.5 | ||
14-Day ATR ($) | 0.062831 | ||
20-Day SMA ($) | 0.50439 | ||
12-1 Month Momentum % | -84.1 | ||
52-Week Range ($) | 0.3704 - 4.38 | ||
Shares Outstanding (Mil) | 13.9 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aethlon Medical Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aethlon Medical Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Aethlon Medical Inc Frequently Asked Questions
What is Aethlon Medical Inc(AEMD)'s stock price today?
The current price of AEMD is $0.45. The 52 week high of AEMD is $4.38 and 52 week low is $0.37.
When is next earnings date of Aethlon Medical Inc(AEMD)?
The next earnings date of Aethlon Medical Inc(AEMD) is 2024-08-09 Est..
Does Aethlon Medical Inc(AEMD) pay dividends? If so, how much?
Aethlon Medical Inc(AEMD) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |